The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies, such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry. , according to GlobalData’s report on Innovation in Medical Devices: Ultrasonic atomizers.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, neurostimulation therapy, smart physiotherapy devices, and real-time IR thermographic imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Precision radiotherapy, electric atomisers, and bio-active prosthesis coating are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bioresorbable stent coating and cryogenic tissue treatment, which are now well established in the industry.
Innovation S-curve for the medical devices industry
Ultrasonic atomiser is a key innovation area in the medical devices industry
Ultrasonic atomizers are utilized to convert liquid into a very fine mist by using high-frequency sound waves. They consist of a generator and a probe. The generator creates vibrations at the tip of the probe and generates fine particles as the liquid passes through the probe.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 30+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of ultrasonic atomisers.
Key players in ultrasonic atomisers – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to ultrasonic atomisers
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Koninklijke Philips||153||Unlock company profile|
|Stamford Devices||101||Unlock company profile|
|Nektar Therapeutics||101||Unlock company profile|
|Eyenovia||91||Unlock company profile|
|Pneuma Respiratory||74||Unlock company profile|
|MicroBase Technology||58||Unlock company profile|
|PARI Medical Holding||56||Unlock company profile|
|Teva Pharmaceutical Industries||55||Unlock company profile|
|Omron||54||Unlock company profile|
|AFT Pharmaceuticals||37||Unlock company profile|
|Johnson & Johnson||33||Unlock company profile|
|L'Oreal||32||Unlock company profile|
|Philip Morris International||19||Unlock company profile|
|Novopyxis||19||Unlock company profile|
|British American Tobacco||17||Unlock company profile|
|AptarGroup||17||Unlock company profile|
|AeroSurgical||16||Unlock company profile|
|Henkel||13||Unlock company profile|
|Health & Life||10||Unlock company profile|
|United Therapeutics||10||Unlock company profile|
|Convexity Scientific||10||Unlock company profile|
|Nortev||10||Unlock company profile|
|Zambon||9||Unlock company profile|
|Vapotherm||9||Unlock company profile|
|Delta Electronics||9||Unlock company profile|
|Funai Electric||8||Unlock company profile|
|Omron Tateisi Electronics||7||Unlock company profile|
|System Assistance Medical||7||Unlock company profile|
|Respira Technologies||6||Unlock company profile|
|Omega Life Science||5||Unlock company profile|
|HEC Pharm Group||5||Unlock company profile|
|HCmed Innovations||5||Unlock company profile|
|Panasonic||5||Unlock company profile|
Source: GlobalData Patent Analytics
Koninklijke Philips is one of the leading patent filers in ultrasonic atomisers. Some other leading patent filers include Nektar Therapeutics, Stamford Devices, Eyenovia, and Pneuma Respiratory.
In terms of application diversity, Johnson & Johnson leads the pack, followed by Zambon and Eyenovia. By means of geographic reach, Johnson & Johnson holds the top position, followed by AFT Pharmaceuticals, and Novopyxis in the second and third spots, respectively.
The use of ultrasonic atomisers is gaining popularity as they are easy to use, compact, environment-friendly, and efficient. Improvements in the design and operating systems are expected to produce more accurate, portable, efficient, and effective ultrasonic nebulizers in the future.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.